Address correspondence to Dr Amaal Jilani Starling, Mayo Clinic, 13400 East Shea Blvd, Scottsdale, AZ 85259, [email protected].
RELATIONSHIP DISCLOSURE: Dr Starling has received personal compensation for serving on the medical advisory boards of Alder BioPharmaceuticals, Inc; Amgen Inc; Eli Lilly and Company; and eNeura Inc and as a consultant for Amgen Inc and Eli Lilly and Company. Dr Starling receives research/grant support from the Mayo Clinic and the Migraine Research Foundation.
UNLABELED USE OF PRODUCTS/INVESTIGATIONAL USE DISCLOSURE: Dr Starling discusses the unlabeled/investigational use of acetazolamide, beta-blockers including nadolol and propranolol, caffeine, celecoxib, clomipramine, clonazepam, cyclobenzaprine, ergotamine, flunarizine, gabapentin, indomethacin, lithium, melatonin, nifedipine, nonsteroidal anti-inflammatory drugs, onabotulinumtoxinA, topiramate, and tricyclic antidepressants including amitriptyline for the treatment of unusual headache disorders.
CONTINUUM AUDIO INTERVIEW AVAILABLE ONLINE